These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

332 related items for PubMed ID: 18568311

  • 1. [Diabetes mellitus and heart failure: epidemiology and therapy].
    Pfister R, Erdmann E.
    Herz; 2008 Apr; 33(3):178-83. PubMed ID: 18568311
    [Abstract] [Full Text] [Related]

  • 2. Type 2 diabetes mellitus and heart failure.
    Choy CK, Rodgers JE, Nappi JM, Haines ST.
    Pharmacotherapy; 2008 Feb; 28(2):170-92. PubMed ID: 18225964
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Heart failure with thiazolidinedione treatment: what do we know today?].
    Erdmann E.
    Dtsch Med Wochenschr; 2009 Jan; 134(4):154-8. PubMed ID: 19148858
    [Abstract] [Full Text] [Related]

  • 6. A comparison of select cardiovascular outcomes by antidiabetic prescription drug classes used to treat type 2 diabetes among Military Health System beneficiaries, fiscal year 2003-2006.
    Casscells SW, Granger E, Swedorske J, Goldhammer R, Shaheen M, Dorris J, Hong A, Wiktor M.
    Am J Ther; 2008 Jan; 15(3):198-205. PubMed ID: 18496256
    [Abstract] [Full Text] [Related]

  • 7. Heart failure and diabetes mellitus: epidemiology and management of an alarming association.
    Cohen-Solal A, Beauvais F, Logeart D.
    J Card Fail; 2008 Sep; 14(7):615-25. PubMed ID: 18722328
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Pantalone et al.: the risk of developing coronary artery disease or congestive heart failure, and overall mortality, in type 2 diabetic patients receiving rosiglitazone, pioglitazone, metformin, or sulfonylureas: a retrospective analysis.
    Bell DS.
    Acta Diabetol; 2009 Jun; 46(2):155; author reply 157. PubMed ID: 19300899
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Is an evidence-based therapy of inpatients with type 2 diabetes possible from studies used for formulating therapy guidelines?].
    Häuser W, Ziehl S, Poltorak P, Grandt D.
    Dtsch Med Wochenschr; 2005 Apr 29; 130(17):1069-73. PubMed ID: 15841421
    [Abstract] [Full Text] [Related]

  • 14. Metformin use in decompensated heart failure.
    Boyd A, Nawarskas J.
    Cardiol Rev; 2008 Apr 29; 16(5):269-72. PubMed ID: 18708828
    [Abstract] [Full Text] [Related]

  • 15. Glycemic control and treatment patterns in patients with heart failure.
    Tang WH.
    Heart Fail Monit; 2006 Apr 29; 5(1):10-4. PubMed ID: 16547530
    [Abstract] [Full Text] [Related]

  • 16. Comorbidity, hypoglycaemia and appropriate selection of antidiabetic pharmacotherapy in diabetic patients with heart failure in clinical practice in Germany. Results of the DiaRegis registry.
    Gitt AK, Bramlage P, Binz C, Krekler M, Deeg E, Tschöpe D.
    Herz; 2012 May 29; 37(3):294-300. PubMed ID: 22476616
    [Abstract] [Full Text] [Related]

  • 17. Metformin use and mortality among patients with diabetes and atherothrombosis.
    Roussel R, Travert F, Pasquet B, Wilson PW, Smith SC, Goto S, Ravaud P, Marre M, Porath A, Bhatt DL, Steg PG, Reduction of Atherothrombosis for Continued Health (REACH) Registry Investigators.
    Arch Intern Med; 2010 Nov 22; 170(21):1892-9. PubMed ID: 21098347
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.